2009
DOI: 10.1371/journal.pone.0007498
|View full text |Cite
|
Sign up to set email alerts
|

Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling

Abstract: BackgroundViruses interact with and exploit the host cellular machinery for their multiplication and propagation. The MEK/ERK signaling pathway positively regulates replication of many RNA viruses. However, whether and how this signaling pathway affects hepatitis C virus (HCV) replication and production is not well understood.Methods and ResultsIn this study, we took advantage of two well-characterized MEK/ERK inhibitors and MEK/ERK dominant negative mutants and investigated the roles of the MEK/ERK signaling … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
12
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 30 publications
3
12
0
Order By: Relevance
“…Other groups also reported that inhibition of MEK/ERK signaling enhanced HCV propagation (26). We showed that silencing of Abi1 resulted in enhancement of ERK activation.…”
Section: Ns5a Interacts With Abi1 and Regulates Mek/erk Signalingsupporting
confidence: 57%
“…Other groups also reported that inhibition of MEK/ERK signaling enhanced HCV propagation (26). We showed that silencing of Abi1 resulted in enhancement of ERK activation.…”
Section: Ns5a Interacts With Abi1 and Regulates Mek/erk Signalingsupporting
confidence: 57%
“…During virus infection, MAPKs can either be utilized to promote virus-specific protein synthesis and subsequent progeny virus production [14,15,42], or act as negative regulators of virus replication [43]. The different MAPK cascades during influenza virus infection serve as novel potential targets for antiviral intervention [44].…”
Section: Discussionmentioning
confidence: 99%
“…Both spectral counting and dimethyl-labeling quantification revealed altered activity in MAPK pathways kinases. As shown in Table 1, the activities of mitogen-activated protein kinase 1 (MAPK1) and dual specificity mitogen-activated protein kinase kinase 1 (MAP2K1), the kinase that activates MAPK1, 63 were downregulated in HCV-containing cells compared to naıve cells (Table 1). Pathway enrichment analysis of differentially active kinases indicates that the MAPK pathway is strongly inhibited by HCV (Table 3).…”
Section: Acs Infectious Diseasesmentioning
confidence: 99%